John Bluth
About John Bluth
John Bluth is the Chief Communications Officer at BioCryst, having joined in April 2019 with extensive experience in IR and corporate communications across life sciences and clean technology sectors.
Chief Communications Officer at BioCryst
John Bluth has been serving as the Chief Communications Officer at BioCryst since April 2019. In this role, he oversees all aspects of corporate communications, ensuring effective internal and external communication strategies to enhance the company's profile and stakeholder engagement.
Career in Investor Relations and Corporate Communications
John Bluth has a rich background in Investor Relations (IR) and Corporate Communications. He has led these functions for both US and international life sciences and clean technology companies. His expertise has been critical in shaping communication strategies and maintaining investor relationships across multiple organizations.
Previous Leadership Roles
Before joining BioCryst, John Bluth held several significant positions. He worked at Cempra, which merged with Melinta Therapeutics in 2017, and at CV Therapeutics and Aviron, both of which were acquired in 2009 and 2002, respectively. He also led the west coast healthcare practice for Fleishman Hillard, an international public relations firm.
Experience with International Firms
From 2009 to 2012, John Bluth was responsible for Investor Relations and Group Communications at the German-based Elster Group. Following this, from 2012 to 2016, he led IR and Corporate Communications for PowerSecure International, Inc. His international experience has equipped him with a diverse perspective on global communication practices.
Educational Background
John Bluth holds a Bachelor's degree in physiology from Cornell University. His academic background in the life sciences provides a strong foundation for his roles in communications within the life sciences and healthcare sectors.